Report cover image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030

Publisher Grand View Research
Published Jul 30, 2024
Length 100 Pages
SKU # GV19065969

Description

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030


Immunoprotein Diagnostic Testing Market Growth & Trends

The global immunoprotein diagnostic testing market size was valued at USD 14.86 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Immunoprotein Diagnostic Testing Market Report Highlights
  • In 2016, immunoglobulin tests dominated the market owing to their frequent usage by healthcare professionals for diagnosing infectious or autoimmune disorders
  • C-Reactive Protein (CRP) tests held a significant market share in 2016 due to the broad product portfolio of these assays and reagents
  • Infectious disease testing held largest market share in 2016 owing to the increasing prevalence of infectious diseases and high applications of immunoprotein tests
  • Enzyme-based immunoassays dominated the market in 2016 due to their frequent usage and availability of large number of products that possess this technology
  • Chemiluminescence assay is anticipated to witness highest growth over the forecast period due to its high sensitivity and specificity
  • North America dominated the market in 2016 due to rising prevalence of cancer & increase in mortality due to cancer-related diseases and favorable healthcare reimbursement scenario in the U.S.
  • Some of the key players of immunoprotein diagnostic testing market are Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enzo Biochem, Inc.; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; bioMC)rieux SA; and Siemens Healthcare GmbH
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Immunoprotein Diagnostic Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunoprotein Diagnostic Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Immunoprotein Diagnostic Testing Market: Test Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Immunoprotein Diagnostic Testing Market: Test Movement Analysis, USD Million, 2023 & 2030
4.3. Complement System Proteins Diagnostic Tests
4.3.1. Complement System Proteins Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Free Light Chain Diagnostic Tests
4.4.1. Free Light Chain Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Haptoglobin Diagnostic Tests
4.5.1. Haptoglobin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Immunoglobulin Diagnostic Tests
4.6.1. Immunoglobulin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Prealbumin Diagnostic Tests
4.7.1. Prealbumin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. C-Reactive Protein (CRP) Diagnostic Tests
4.8.1. C-Reactive Protein (CRP) Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Immunoprotein Diagnostic Testing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Immunoprotein Diagnostic Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Infectious Disease Testing
5.3.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oncology Testing
5.4.1. Oncology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Endocrine Testing
5.5.1. Endocrine Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Toxicology Testing
5.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Allergy Testing
5.7.1. Allergy Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autoimmune Disease Testing
5.8.1. Autoimmune Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Immunoprotein Diagnostic Testing Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Immunoprotein Diagnostic Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Radioimmunoassay
6.3.1. Radioimmunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Enzyme Based Immunoassay
6.4.1. Enzyme Based Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Chemiluminescence Assay
6.5.1. Chemiluminescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Immunofluorescence Assay
6.6.1. Immunofluorescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoturbidity Assay
6.7.1. Immunoturbidity Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Immunoprotein Electrophoresis
6.8.1. Immunoprotein Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Immunoprotein Diagnostic Testing Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Immunoprotein Diagnostic Testing Market: Material Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals and Clinics
7.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Immunoprotein Diagnostic Testing Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Immunoprotein Diagnostic Testing Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
8.3. Direct Tender
8.3.1. Direct Tender Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Retail Sales
8.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Immunoprotein Diagnostic Testing Market: Regional Estimates & Trend Analysis
9.1. Immunoprotein Diagnostic Testing Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK.
9.3.2.1. UK Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Norway Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. India
9.4.3.1. India Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. Japan
9.4.4.1. Japan Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Australia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. South Korea Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. UAE Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Agilent Technologies, Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. Danaher Corporation.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Thermo Fisher Scientific Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. PerkinElmer Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Aurora Biomed Inc.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Tecan Trading AG
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Promega Corporation.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Charles River Laboratories
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Creative Biolabs
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us